Findings shown in Figure 5E support animal data shown in Figure 4A, such that anti-EGFR/VEGFR2 BsAb demonstrated more potent inhibitory activity than corresponding mAbs toward tumor grow. This evidence concerns the gene EGFR and neoplasm.